Skip to main content
SpringerLink
Log in

The Patient Labeling Program at Bristol-Myers Squibb

  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

Among the goals of the Department of Health and Human Services and the Food and Drug Administration (FDA) is to improve written communication to patients about their prescription medicines. Bristol-Myers Squibb Company recognizes the need for patients to receive high-quality information regarding their therapeutic options. The company has initiated a program to prepare patient-oriented labeling for certain prescription products for which such material is appropriate, using the FDA’s proposed Medication Guide as a basis for content and format.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Federal Register. 1968;33:8812 (21 CFR 201.305).

  2. Federal Register. 1970;35:9O01 (21 CFR 310.501).

  3. Federal Register. 1977;42:37636 (21 CFR 310.515).

  4. Federal Register. 1978;43:47198 (21 CFR 310.516).

  5. Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. Action Plan for the Provision of Useful Prescription Medicine Information. December 1996: 11.

  6. Federal Register. 1979;44:40016.

  7. Federal Register. 1980;45:60754.

  8. Federal Register. 1981;46:13193.

  9. Federal Register. 1981;46:23739.

  10. Federal Register. 1982;47:39147.

  11. Federal Register. 1995;60:44182.

  12. HR 104-180.

  13. Federal Register. 1995;60:44199.

  14. Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. Action Plan for the Provision of Useful Prescription Medicine Information. December 1996: 3.

  15. Federal Register. 1998;63:66378-66400.

  16. Jones S, et al. Patient information leaflets for HIV positive patients. Pharmaceut J. Sep 8, 1990;245: 308–309.

    Google Scholar 

  17. Fleckenstein L, et al. Oral contraceptive patient information-a questionnaire study of attitudes, knowledge, and preferred information sources. JAMA. 1976; 235(13):1331–1336.

    Article  CAS  Google Scholar 

  18. Smith D. Compliance packaging: a patient education tool. Am Pharmacy. Feb 2, 1989;NS29(2):126–137.

    Google Scholar 

  19. Kuperberg JR, et al. All in one: the user-friendly rx product. Pharmaceut Exec. April 1990:74–78.

    Google Scholar 

  20. Gibbs S, et al. The benefits of prescription information leaflets (1). Br J Clin Pharmacol. 1989;27:723–739.

    Article  CAS  Google Scholar 

  21. George CF, et al. Prescription information leaflets: a pilot study in general practice. Brit Med J 1983; 287:1193–1196.

    Article  CAS  Google Scholar 

  22. Glazier R, et al. Written patient information about triple-market screening: a randomized, controlled trial. Obstet Gynecol. November 1997;90(5):769–774.

    Article  CAS  Google Scholar 

  23. National Institute of Health. Minimizing Medical Product Errors, A Systems Approach, Bethesda, MD; Jan. 8, 1998.

    Google Scholar 

  24. Sless D, Wiseman R. Writing about Medicines for People-Usability Guidelines for Consumer Medicine Information. 2nd ed. Communication Research Institute of Australia. Dickson, Australia. Ch 6, 73-96, Appendices 3, 4, 5, 121-157.

Download references

Author information

Authors and Affiliations

  1. U.S. and Export Labeling, Bristol-Myers Squibb Company, Princeton, New Jersey, 08543-4000, USA, PO Box 4000

    Cathleen A. O’Connell (Director)

  2. Bristol-Myers Squibb Company, Wallingford, Connecticut, USA

    Rebecca Skinner (Senior U.S. Labeling Associate)

Authors
  1. Cathleen A. O’Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca Skinner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Connell, C.A., Skinner, R. The Patient Labeling Program at Bristol-Myers Squibb. Ther Innov Regul Sci 33, 649–654 (1999). https://doi.org/10.1177/009286159903300301

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286159903300301

Key Words

Search

Navigation